MediWound Return on Equity (ROE) Growth & History (MDWD)

MediWound's return on equity was −63.86% for fiscal 2025.

View full MediWound company overview

MediWound annual return on equity history

MediWound annual return on equity

Fiscal yearPeriod endedReturn on equityChange (percentage points)
20252025-12-31−63.86%+32.47 pp
20242024-12-31−96.33%−64.74 pp
20232023-12-31−31.60%+587.45 pp
20222022-12-31−619.05%+388.46 pp
20212021-12-31−1,007.51%−925.55 pp
20202020-12-31−81.96%−123.01 pp
20192019-12-3141.05%+52.58 pp
20182018-12-31−11.52%+246.91 pp
20172017-12-31−258.43%−137.53 pp
20162016-12-31−120.90%

MediWound return on equity trends

Over the last five fiscal years, MediWound's return on equity increased from −81.96% to −63.86%, a change of +18.10 percentage points. The latest reported quarter, Q2 2026, shows −19.18%.

About the metric

What return on equity (ROE) means

Return on equity (ROE) measures how much net income a company generates relative to shareholders’ equity. It can help evaluate how efficiently equity capital is used, but unusually high or negative values may reflect leverage, losses, or a small equity base.

Calculation and source

How return on equity is calculated

TickerStat calculates ROE as SEC-reported net income divided by average stockholders’ equity at the beginning and end of the fiscal period. Periods with missing or non-positive average equity are omitted. Quarterly ROE uses quarterly net income and is not annualized. Fiscal periods can differ from calendar years, so exact period-end dates are included.

Review MediWound source filings ↗

Community posts

It’s quiet here.

No posts about MDWD yet. Start the conversation.

Write the first post